Anti-tumour necrosis factor-alpha therapies in Crohn's disease
- PMID: 20081592
- DOI: 10.12968/hmed.2009.70.11.45055
Anti-tumour necrosis factor-alpha therapies in Crohn's disease
Abstract
This article reviews the limitations of existing Crohn's disease therapies and the efficacy and safety of anti-tumour necrosis factor-alpha drugs. Trying to determine which patients may benefit from these therapies while minimizing toxicity is key. Special treatment situations and future developments are also briefly discussed.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
